USPTO 2015–2025 USPTO PatentsView US Corporation

Walk Vascular, LLC

USPTO PatentsView assignee record - 16 granted patents across 2 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Walk ranks #18,278 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 2 technology areas.

#18,278
of 49,997 US assignees by volume
Top 21%
by Innovation Score (46.5/100)
19.6
avg claims per patent
+450%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18278 · US Corporation #18,278 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 16 grants
  • MID-PACK #18,278/49,997
  • PHOTO-FINISH Warby Parker
  • CPC-NARROW A61B · 2 areas
  • INNOV-PAR 46.5/100
  • CLAIMS-RICH 19.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +450% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Warby Parker Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Walk’s 46.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Walk

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Walk's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Walk?

Each dot is one of Walk’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Walk’s own 19.6 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Walk vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 15.915.91616.1 0102030 Granted patents (volume) Avg claims / patent Willand (BEIJING) Technology Co., Ltd. - 16, 11Willand (Beijing)…Wisilica Inc. - 16, 12.75WisilicaWombat Security Technologies, Inc. - 16, 25Wombat SecurityWsou Investments, LLC - 16, 17.62Wsou InvestmentsWarby Parker Inc. - 16, 14.69Warby ParkerWaterFurnace International, Inc. - 16, 18.94Waterfurnace Inte…Wave Sciences, LLC - 16, 16.5Wave SciencesWawona Packing Co., LLC - 16, 1Wawona PackingWalk Vascular, LLC - 16, 19.56Walk Vascular
Walk vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Walk's grants concentrate

Walk Vascular, LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2018. By volume, Walk sits between Willand (BEIJING) Technology Co., Ltd. and Wawona Packing Co., LLC.

Walk's three-year grant acceleration

Walk Vascular, LLC shows 10 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Walk's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Walk holds 16 patents at rank #18,284, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Walk

By rank, the assignees closest to #18,284 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Walk's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Walk, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Walk ranks #1,103 of 7,127 assignees by patent count in that subclass.

Walk's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 21% higher than 79% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2018201920202022202320242025 3
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Walk Vascular, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 6.3%
2019 1 6.3%
2020 1 6.3%
2022 3 18.8%
2023 3 18.8%
2024 4 25.0%
2025partial year 3 18.8%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Walk Vascular, LLC's patent record in context - here's where to go next.

  • Walk Vascular, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #18,278 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Walk Vascular, LLC against Willand (BEIJING) Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.